Predicting 3-year mortality after percutaneous coronary intervention: Updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials

JACC: Cardiovascular Interventions

Volumn 7, Issue 5, 2014, Pages 464-470

  Iqbal, Javaid ^a,b   Vergouwe, Yvonne ^c   Bourantas, Christos V ^a   Klaveren, David V ^c   Zhang, Yao Jun ^a   Campos, Carlos M ^a   García García, Hector M ^d   Morel, Marie Angele ^d   Valgimigli, Marco ^a   Windecker, Stephan ^e   Steyerberg, Ewout W ^b   Serruys, Patrick W ^a,f  

^a Department of Interventional Cardiology Thoraxcenter ^*  (Netherlands)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d CARDIALYSIS   (Netherlands)

^e UNIVERSITY OF BERN   (Switzerland)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

logistic clinical SYNTAX score; percutaneous coronary intervention; risk stratification; SYNTAX score

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL (TOPIC); CORONARY STENT; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LONG TERM SURVIVAL; LOW RISK PATIENT; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SYNTAX SCORE; TREATMENT OUTCOME; AGE DISTRIBUTION; ANGIOGRAPHY; BODY MASS; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HYPERLIPIDEMIA; INTERMEDIATE RISK POPULATION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; STATISTICAL MODEL; TIME;

AGED; CLINICAL TRIALS AS TOPIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901281358     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.02.007     Document Type: Article

References (41)

1. P.W. Serruys, M.C. Morice, and A.P. Kappetein et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
2. G. Sianos, M.A. Morel, and A.P. Kappetein et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
3. J.J. Wykrzykowska, S. Garg, and C. Girasis et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial J Am Coll Cardiol 56 2010 272 277
4. S. Garg, P.W. Serruys, and S. Silber et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial J Am Coll Cardiol Intv 4 2011 432 441
5. M. Valgimigli, P.W. Serruys, and K. Tsuchida et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention Am J Cardiol 99 2007 1072 1081
6. S. Garg, G. Sarno, and H.M. Garcia-Garcia et al. A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score Circ Cardiovasc Interv 3 2010 317 326
7. V. Farooq, Y. Vergouwe, and L. Raber et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score Eur Heart J 33 2012 3098 3104
8. V. Farooq, Y. Vergouwe, and P. Genereux et al. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score J Am Coll Cardiol Intv 6 2013 737 745
9. S. Windecker, A. Remondino, and F.R. Eberli et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662
10. P.W. Serruys, A.T. Ong, and M.C. Morice et al. Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions EuroIntervention 1 2005 147 156
11. M. Valgimigli, G. Percoco, and P. Malagutti et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial JAMA 293 2005 2109 2117
12. M. Valgimigli, G. Campo, and G. Percoco et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799
13. S. Windecker, P.W. Serruys, and S. Wandel et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial Lancet 372 2008 1163 1173
14. P.W. Serruys, S. Silber, and S. Garg et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
15. M. Ranucci, S. Castelvecchio, L. Menicanti, A. Frigiola, and G. Pelissero Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony Circulation 119 2009 3053 3061
16. Y. Vergouwe, E.W. Steyerberg, M.J. Eijkemans, and J.D. Habbema Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol 20 2002 96 107
17. F.W. Mohr, M.C. Morice, and A.P. Kappetein et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Lancet 381 2013 629 638
18. D. Capodanno, M.E. Di Salvo, G. Cincotta, M. Miano, C. Tamburino, and C. Tamburino Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease Circ Cardiovasc Interv 2 2009 302 308
19. Y.H. Kim, D.W. Park, and W.J. Kim et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization J Am Coll Cardiol Intv 3 2010 612 623
20. G. Montalescot, U. Sechtem, and S. Achenbach et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 2013 2949 3003
21. V. Farooq, D. van Klaveren, and E.W. Steyerberg et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381 2013 639 650
22. M.E. Farkouh, M. Domanski, and L.A. Sleeper et al. Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
23. M.E. Buschur, D. Smith, and D. Share et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium J Am Coll Cardiol 62 2013 685 691
24. R.M. Minutello, E.T. Chou, and M.K. Hong et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry) Am J Cardiol 93 2004 1229 1232
25. L. Gruberg, N.J. Weissman, and R. Waksman et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39 2002 578 584
26. S. Midwall, R.V. Swaminathan, and K. Charitakis et al. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era J Invasive Cardiol 25 2013 132 136
27. M. Singh, R.J. Lennon, D. Darbar, B.J. Gersh, D.R. Holmes Jr., and C.S. Rihal Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents Mayo Clin Proc 79 2004 1113 1118
28. J. Saw, D.L. Bhatt, and D.J. Moliterno et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials J Am Coll Cardiol 48 2006 1567 1572
29. E.D. Peterson, D. Dai, and E.R. DeLong et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry J Am Coll Cardiol 55 2010 1923 1932
30. M. Singh, C.S. Rihal, F. Selzer, K.E. Kip, K. Detre, and D.R. Holmes Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry J Am Coll Cardiol 42 2003 1722 1728
31. M. de Mulder, A. Gitt, and R. van Domburg et al. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention Eur Heart J 32 2011 1398 1408
32. C. Wu, E.L. Hannan, and G. Walford et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions J Am Coll Cardiol 47 2006 654 660
33. S.L. Chen, J.P. Chen, and G. Mintz et al. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting J Am Coll Cardiol Intv 3 2010 632 641
34. S.L. Chen, Y.L. Han, and Y.J. Zhang et al. The Anatomic- and Clinical-Based NERS (New Risk Stratification) Score II to Predict Clinical Outcomes After Stenting Unprotected Left Main Coronary Artery Disease: results from a multicenter, prospective, registry study J Am Coll Cardiol Intv 6 2013 1233 1241
35. SYNTAX Score. Available at http://www.syntaxscore.com. Accessed April 10, 2014.
36. P. Genereux, T. Palmerini, and A. Caixeta et al. SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements Circ Cardiovasc Interv 4 2011 553 561
37. D. Capodanno, M. Miano, and G. Cincotta et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention Am Heart J 159 2010 103 109
38. D. Capodanno, A. Caggegi, and M. Miano et al. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization J Am Coll Cardiol Intv 4 2011 287 297
39. P.W. Serruys, V. Farooq, and P. Vranckx et al. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX trial at 3 years J Am Coll Cardiol Intv 5 2012 606 617
40. J. Iqbal, W. Sumaya, and V. Tatman et al. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting EuroIntervention 9 2013 62 69
41. J. Iqbal, P.W. Serruys, and D.P. Taggart Optimal revascularization for complex coronary artery disease Nat Rev Cardiol 10 2013 635 647